These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

736 related articles for article (PubMed ID: 20019167)

  • 1. New insights into epithelial-mesenchymal transition in kidney fibrosis.
    Liu Y
    J Am Soc Nephrol; 2010 Feb; 21(2):212-22. PubMed ID: 20019167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention.
    Liu Y
    J Am Soc Nephrol; 2004 Jan; 15(1):1-12. PubMed ID: 14694152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role for integrin-linked kinase in mediating tubular epithelial to mesenchymal transition and renal interstitial fibrogenesis.
    Li Y; Yang J; Dai C; Wu C; Liu Y
    J Clin Invest; 2003 Aug; 112(4):503-16. PubMed ID: 12925691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New insights into the regulation of epithelial-mesenchymal transition and tissue fibrosis.
    Lee K; Nelson CM
    Int Rev Cell Mol Biol; 2012; 294():171-221. PubMed ID: 22364874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal interstitial fibrosis: a critical evaluation of the origin of myofibroblasts.
    Barnes JL; Glass Ii WF
    Contrib Nephrol; 2011; 169():73-93. PubMed ID: 21252512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epithelial-mesenchymal transition in renal fibrosis - evidence for and against.
    Fragiadaki M; Mason RM
    Int J Exp Pathol; 2011 Jun; 92(3):143-50. PubMed ID: 21554437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epithelial-mesenchymal plasticity in kidney fibrosis.
    Hadpech S; Thongboonkerd V
    Genesis; 2024 Feb; 62(1):e23529. PubMed ID: 37345818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of tubular phenotypic changes on the development of diffuse interstitial fibrosis in renal allografts.
    Özdemir BH; Özdemir AA; Colak T; Sezer S; Haberal M
    Transplant Proc; 2011 Mar; 43(2):527-9. PubMed ID: 21440751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging Therapeutic Strategies for Attenuating Tubular EMT and Kidney Fibrosis by Targeting Wnt/β-Catenin Signaling.
    Hu L; Ding M; He W
    Front Pharmacol; 2021; 12():830340. PubMed ID: 35082683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of tubular epithelial-mesenchymal transition in progressive kidney disease.
    Burns WC; Kantharidis P; Thomas MC
    Cells Tissues Organs; 2007; 185(1-3):222-31. PubMed ID: 17587828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PINCH-1 promotes tubular epithelial-to-mesenchymal transition by interacting with integrin-linked kinase.
    Li Y; Dai C; Wu C; Liu Y
    J Am Soc Nephrol; 2007 Sep; 18(9):2534-43. PubMed ID: 17656471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The molecular mediators of type 2 epithelial to mesenchymal transition (EMT) and their role in renal pathophysiology.
    Burns WC; Thomas MC
    Expert Rev Mol Med; 2010 May; 12():e17. PubMed ID: 20504380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EMT and proteinuria as progression factors.
    Strutz FM
    Kidney Int; 2009 Mar; 75(5):475-81. PubMed ID: 18716603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of epithelial-to-mesenchymal transition in renal fibrosis.
    Zeisberg M; Kalluri R
    J Mol Med (Berl); 2004 Mar; 82(3):175-81. PubMed ID: 14752606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hesperetin inhibit EMT in TGF-β treated podocyte by regulation of mTOR pathway.
    Choi D; Kim CL; Kim JE; Mo JS; Jeong HS
    Biochem Biophys Res Commun; 2020 Jul; 528(1):154-159. PubMed ID: 32451085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy.
    Ziyadeh FN; Wolf G
    Curr Diabetes Rev; 2008 Feb; 4(1):39-45. PubMed ID: 18220694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epithelial-mesenchymal transition as a potential explanation for podocyte depletion in diabetic nephropathy.
    Yamaguchi Y; Iwano M; Suzuki D; Nakatani K; Kimura K; Harada K; Kubo A; Akai Y; Toyoda M; Kanauchi M; Neilson EG; Saito Y
    Am J Kidney Dis; 2009 Oct; 54(4):653-64. PubMed ID: 19615802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parathyroid hormone-related protein promotes epithelial-mesenchymal transition.
    Ardura JA; Rayego-Mateos S; Rámila D; Ruiz-Ortega M; Esbrit P
    J Am Soc Nephrol; 2010 Feb; 21(2):237-48. PubMed ID: 19959711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The epithelial-mesenchymal transition and fibrosis of the renal transplant].
    Mezni I; Galichon P; Bacha MM; Sfar I; Hertig A; Goucha R; Xu-Dubois YC; Abderrahim E; Gorgi Y; Rondeau E; Abdallah TB
    Med Sci (Paris); 2015 Jan; 31(1):68-74. PubMed ID: 25658733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of integrin-linked kinase blocks podocyte epithelial-mesenchymal transition and ameliorates proteinuria.
    Kang YS; Li Y; Dai C; Kiss LP; Wu C; Liu Y
    Kidney Int; 2010 Aug; 78(4):363-73. PubMed ID: 20505657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.